Argenx's CFO commented to Reuters regarding market status, following Vyvgart's approval for use in Japan.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Argenx's CFO commented to Reuters regarding market status, following Vyvgart's approval for use in Japan.